Oxycontin manufacturer cuts entire sales team



The Daily Caller Reports the pharmaceutical giant behind the painkiller OxyContin revealed it cut its entire remaining sales team in a shift away from opioids. Purdue Pharma announced the changes Tuesday, which will effectively end any contact the company has with medical providers regarding their medications. The company says that while it will still manufacture opioid-based medications, it is shifting primary focus to research and development into medications aimed at treating cancer and central nervous system disorders. Get free legal news daily from News.law